Identification of a novel coronavirus causing severe pneumonia in human: a descriptive studyLi-li Ren, Jianwei Wang, Yongjun Li et al.|Chinese Medical Journal|2020Cited by 1.4k
Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trialYuankai Shi, Peng Liu, Hang Su et al.|The Lancet Haematology|2019Cited by 248
Circulating tumor DNA predicts response in Chinese patients with relapsed or refractory classical hodgkin lymphoma treated with sintilimabYuankai Shi, Bo Peng, Hang Su et al.|EBioMedicine|2020Cited by 41
Immunohistochemical detection of mutations in the epidermal growth factor receptor gene in lung adenocarcinomas using mutation-specific antibodiesYan Xiong, Ting Li|Diagnostic Pathology|2013Cited by 33